Lung surfactant protein D (SP-D) response and regulation during acute and chronic lung injury

Maria Quisgaard Gaunsbaek, Karina Juhl Rasmussen, Michael F. Beers, Elena N. Atochina-Vasserman, Soren Hansen

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background: Surfactant protein D (SP-D) is a collection that plays important roles in modulating host defense functions and maintaining phospholipid homeostasis in the lung. The aim of current study was to characterize comparatively the SP-D response in bronchoalveolar lavage (BAL) and serum in three murine models of lung injury, using a validated ELISA technology for estimation of SP-D levels. Methods: Mice were exposed to lipopolysaccharide, bleomycin, or Pneumocystis carinii (Pc) and sacrificed at different time points. Results: In lipopolysaccharide-challenged mice, the level of SP-D in BAL increased within 6 h, peaked at 51 h (4,518 ng/ml), and returned to base level at 99 h (612 ng/ml). Serum levels of SP-D increased immediately (8.6 ng/ml), peaked at 51 h (16 ng/ml), and returned to base levels at 99 h (3.8 ng/ml). In a subacute bleomycin inflammation model, SP-D levels were 4,625 and 367 ng/ml in BAL and serum, respectively, 8 days after exposure. In a chronic Pc inflammation model, the highest level of SP-D was observed 6 weeks after inoculation, with BAL and serum levels of 1,868 and 335 ng/ml, respectively. Conclusions: We conclude that serum levels of SP-D increase during lung injury, with a sustained increment during chronic inflammation compared with acute inflammation. A quick upregulation of SP-D in serum in response to acute airway inflammation supports the notion that SP-D translocates from the airways into the vascular system, in favor of being synthesized systemically. The study also confirms the concept of using increased SP-D serum levels as a biomarker of especially chronic airway inflammation.

Original languageEnglish
Pages (from-to)295-303
Number of pages9
JournalLung
Volume191
Issue number3
DOIs
Publication statusPublished - Jun 2013
Externally publishedYes

Fingerprint

Pulmonary Surfactant-Associated Proteins
Pulmonary Surfactant-Associated Protein D
Acute Lung Injury
Lung Injury
Bronchoalveolar Lavage
Inflammation
Serum
Pneumocystis carinii
Bleomycin
Lipopolysaccharides
Blood Vessels

Keywords

  • Bleomycin
  • Bronchoalveolar lavage
  • Lipopolysaccharide
  • Lung injury
  • Pneumocystis carinii
  • Surfactant protein D

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Lung surfactant protein D (SP-D) response and regulation during acute and chronic lung injury. / Gaunsbaek, Maria Quisgaard; Rasmussen, Karina Juhl; Beers, Michael F.; Atochina-Vasserman, Elena N.; Hansen, Soren.

In: Lung, Vol. 191, No. 3, 06.2013, p. 295-303.

Research output: Contribution to journalArticle

Gaunsbaek, Maria Quisgaard ; Rasmussen, Karina Juhl ; Beers, Michael F. ; Atochina-Vasserman, Elena N. ; Hansen, Soren. / Lung surfactant protein D (SP-D) response and regulation during acute and chronic lung injury. In: Lung. 2013 ; Vol. 191, No. 3. pp. 295-303.
@article{509d2c0fb7b9402e9940b27caa555bfc,
title = "Lung surfactant protein D (SP-D) response and regulation during acute and chronic lung injury",
abstract = "Background: Surfactant protein D (SP-D) is a collection that plays important roles in modulating host defense functions and maintaining phospholipid homeostasis in the lung. The aim of current study was to characterize comparatively the SP-D response in bronchoalveolar lavage (BAL) and serum in three murine models of lung injury, using a validated ELISA technology for estimation of SP-D levels. Methods: Mice were exposed to lipopolysaccharide, bleomycin, or Pneumocystis carinii (Pc) and sacrificed at different time points. Results: In lipopolysaccharide-challenged mice, the level of SP-D in BAL increased within 6 h, peaked at 51 h (4,518 ng/ml), and returned to base level at 99 h (612 ng/ml). Serum levels of SP-D increased immediately (8.6 ng/ml), peaked at 51 h (16 ng/ml), and returned to base levels at 99 h (3.8 ng/ml). In a subacute bleomycin inflammation model, SP-D levels were 4,625 and 367 ng/ml in BAL and serum, respectively, 8 days after exposure. In a chronic Pc inflammation model, the highest level of SP-D was observed 6 weeks after inoculation, with BAL and serum levels of 1,868 and 335 ng/ml, respectively. Conclusions: We conclude that serum levels of SP-D increase during lung injury, with a sustained increment during chronic inflammation compared with acute inflammation. A quick upregulation of SP-D in serum in response to acute airway inflammation supports the notion that SP-D translocates from the airways into the vascular system, in favor of being synthesized systemically. The study also confirms the concept of using increased SP-D serum levels as a biomarker of especially chronic airway inflammation.",
keywords = "Bleomycin, Bronchoalveolar lavage, Lipopolysaccharide, Lung injury, Pneumocystis carinii, Surfactant protein D",
author = "Gaunsbaek, {Maria Quisgaard} and Rasmussen, {Karina Juhl} and Beers, {Michael F.} and Atochina-Vasserman, {Elena N.} and Soren Hansen",
year = "2013",
month = "6",
doi = "10.1007/s00408-013-9452-x",
language = "English",
volume = "191",
pages = "295--303",
journal = "Lung",
issn = "0341-2040",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Lung surfactant protein D (SP-D) response and regulation during acute and chronic lung injury

AU - Gaunsbaek, Maria Quisgaard

AU - Rasmussen, Karina Juhl

AU - Beers, Michael F.

AU - Atochina-Vasserman, Elena N.

AU - Hansen, Soren

PY - 2013/6

Y1 - 2013/6

N2 - Background: Surfactant protein D (SP-D) is a collection that plays important roles in modulating host defense functions and maintaining phospholipid homeostasis in the lung. The aim of current study was to characterize comparatively the SP-D response in bronchoalveolar lavage (BAL) and serum in three murine models of lung injury, using a validated ELISA technology for estimation of SP-D levels. Methods: Mice were exposed to lipopolysaccharide, bleomycin, or Pneumocystis carinii (Pc) and sacrificed at different time points. Results: In lipopolysaccharide-challenged mice, the level of SP-D in BAL increased within 6 h, peaked at 51 h (4,518 ng/ml), and returned to base level at 99 h (612 ng/ml). Serum levels of SP-D increased immediately (8.6 ng/ml), peaked at 51 h (16 ng/ml), and returned to base levels at 99 h (3.8 ng/ml). In a subacute bleomycin inflammation model, SP-D levels were 4,625 and 367 ng/ml in BAL and serum, respectively, 8 days after exposure. In a chronic Pc inflammation model, the highest level of SP-D was observed 6 weeks after inoculation, with BAL and serum levels of 1,868 and 335 ng/ml, respectively. Conclusions: We conclude that serum levels of SP-D increase during lung injury, with a sustained increment during chronic inflammation compared with acute inflammation. A quick upregulation of SP-D in serum in response to acute airway inflammation supports the notion that SP-D translocates from the airways into the vascular system, in favor of being synthesized systemically. The study also confirms the concept of using increased SP-D serum levels as a biomarker of especially chronic airway inflammation.

AB - Background: Surfactant protein D (SP-D) is a collection that plays important roles in modulating host defense functions and maintaining phospholipid homeostasis in the lung. The aim of current study was to characterize comparatively the SP-D response in bronchoalveolar lavage (BAL) and serum in three murine models of lung injury, using a validated ELISA technology for estimation of SP-D levels. Methods: Mice were exposed to lipopolysaccharide, bleomycin, or Pneumocystis carinii (Pc) and sacrificed at different time points. Results: In lipopolysaccharide-challenged mice, the level of SP-D in BAL increased within 6 h, peaked at 51 h (4,518 ng/ml), and returned to base level at 99 h (612 ng/ml). Serum levels of SP-D increased immediately (8.6 ng/ml), peaked at 51 h (16 ng/ml), and returned to base levels at 99 h (3.8 ng/ml). In a subacute bleomycin inflammation model, SP-D levels were 4,625 and 367 ng/ml in BAL and serum, respectively, 8 days after exposure. In a chronic Pc inflammation model, the highest level of SP-D was observed 6 weeks after inoculation, with BAL and serum levels of 1,868 and 335 ng/ml, respectively. Conclusions: We conclude that serum levels of SP-D increase during lung injury, with a sustained increment during chronic inflammation compared with acute inflammation. A quick upregulation of SP-D in serum in response to acute airway inflammation supports the notion that SP-D translocates from the airways into the vascular system, in favor of being synthesized systemically. The study also confirms the concept of using increased SP-D serum levels as a biomarker of especially chronic airway inflammation.

KW - Bleomycin

KW - Bronchoalveolar lavage

KW - Lipopolysaccharide

KW - Lung injury

KW - Pneumocystis carinii

KW - Surfactant protein D

UR - http://www.scopus.com/inward/record.url?scp=84878696706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878696706&partnerID=8YFLogxK

U2 - 10.1007/s00408-013-9452-x

DO - 10.1007/s00408-013-9452-x

M3 - Article

C2 - 23435873

AN - SCOPUS:84878696706

VL - 191

SP - 295

EP - 303

JO - Lung

JF - Lung

SN - 0341-2040

IS - 3

ER -